• 1. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551

Methyl 1-amino-3,3-dimethylcyclohexane-1-carboxylate Hydrochloride (CAS No. 2031258-74-7): An Overview

Methyl 1-amino-3,3-dimethylcyclohexane-1-carboxylate hydrochloride (CAS No. 2031258-74-7) is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as MADCH for brevity, is a derivative of cyclohexane and is characterized by its unique structural features and potential biological activities.

The chemical structure of MADCH consists of a cyclohexane ring with a methyl group and an amino group attached to the same carbon atom, along with a carboxylate ester group. The presence of the hydrochloride salt form ensures its solubility in aqueous solutions, making it suitable for various applications in biological systems. The compound's molecular formula is C₁₁H₂₀ClNO₂, and its molecular weight is approximately 239.73 g/mol.

In recent years, MADCH has been the subject of extensive research due to its potential therapeutic applications. Studies have shown that this compound exhibits significant biological activities, including anti-inflammatory, analgesic, and neuroprotective effects. These properties make it a promising candidate for the development of new drugs targeting various diseases and conditions.

One of the key areas of interest in the research on MADCH is its anti-inflammatory properties. Inflammation is a complex biological response to harmful stimuli such as pathogens, damaged cells, or irritants. Chronic inflammation is associated with numerous diseases, including arthritis, cardiovascular disease, and neurodegenerative disorders. Preclinical studies have demonstrated that MADCH can effectively reduce inflammation by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. This makes it a potential therapeutic agent for treating inflammatory conditions.

Beyond its anti-inflammatory effects, MADCH has also shown promise in pain management. Pain is a significant clinical challenge, and current treatments often come with side effects or limited efficacy. Research has indicated that MADCH can act as an analgesic by modulating pain signaling pathways in the central nervous system. Specifically, it has been shown to inhibit the activation of nociceptors and reduce the release of pain-inducing substances such as substance P. These findings suggest that MADCH could be developed into a novel analgesic drug with fewer side effects compared to existing options.

In addition to its anti-inflammatory and analgesic properties, MADCH has been investigated for its neuroprotective effects. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease are characterized by the progressive loss of neurons and cognitive decline. Studies have shown that MADCH can protect neurons from oxidative stress and apoptosis by upregulating antioxidant enzymes and inhibiting the activation of caspases. This neuroprotective activity makes it a potential candidate for the treatment of neurodegenerative disorders.

The mechanism of action of MADCH is not yet fully understood, but recent research has provided some insights. It appears to interact with multiple targets in the body, including receptors involved in inflammation, pain signaling, and neuroprotection. For example, it may bind to G-protein coupled receptors (GPCRs) or ion channels to modulate cellular responses. Further studies are needed to elucidate the exact mechanisms by which MADCH exerts its biological effects.

Clinical trials are currently underway to evaluate the safety and efficacy of MADCH in humans. Early results from phase I trials have shown that the compound is well-tolerated at various doses and does not cause significant adverse effects. Phase II trials are planned to assess its therapeutic potential in specific patient populations suffering from inflammatory conditions, chronic pain, or neurodegenerative diseases.

In conclusion, methyl 1-amino-3,3-dimethylcyclohexane-1-carboxylate hydrochloride (MADCH) (CAS No. 2031258-74-7) is a promising compound with diverse biological activities that make it a valuable candidate for drug development. Its anti-inflammatory, analgesic, and neuroprotective properties offer potential therapeutic benefits for various diseases and conditions. Ongoing research and clinical trials will continue to explore its full potential and pave the way for new treatments in medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)